diarrhea from retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide Half Life: A Doctor

The litigation stems from a 2021 lawsuit filed by former Bard worker Gary Walker, who alleged that decades of exposure to ethylene oxide emissions from the companies Covington, Georgia sterilization facility caused his cancer

Many patients see better, more durable results when it's built into a structured weight loss program that addresses nutrition and training from day one, rather than relying on the medication by itself

Weekly semaglutide (GLP-1) injections have shown promising results in both clinical trials and real-world practice for weight loss and metabolic improvement

These medications work by reducing appetite, increasing feelings of fullness, and slowing digestion, which helps decrease calorie intake and promotes sustainable weight loss

Rigorous clinical trials are needed to determine whether any observed benefits represent genuine therapeutic effects beyond weight reduction alone

Reduced mental chatter about food represents an early sign of psychological benefit